CONOR MEDSYSTEMS TO PRESENT COSTAR II DATA AT EUROPCR.
Conor Medsystems, Inc. Menlo Park, Calif., will present the results
for its COSTAR II U.S. pivotal clinical trial at the EuroPCR meeting in
Barcelona in May.
"The last patient was followed-up in . . .
SIROCCO TRIAL SHOWS MINIMAL RESTENOSIS RATES WITH CORDIS
STENT.(Clinical report)
Results of the SIROCCO Trial (Sirolimus-Coated Cordis
Self-expandable Stent) evaluating the effectiveness of the S.M.A.R.T.(R)
nitinol self-expandable stent for the treatment of . . .
FDA APPROVES CORDIS DEVICES TO TREAT CLOGGED NECK
ARTERIES.
The Cordis Endovascular Division of Cordis Corporation, Scottsdale,
Ariz., has received FDA approval to market its PRECISE(R) RX Nitinol
Self-Expanding Stent and ANGIOGUARD(R) RX Emboli Capture . . .
MORE THAN 100 NIOBE SYSTEMS ORDERED WORLDWIDE.
Stereotaxis, Inc. (NASDAQ:STXS) St Louis, has announced that
cardiologists have performed more than 6,000 clinical cases using its
advanced magnetic navigation technology, including over . . .
FDA APPROVES EV3'S PROTEGE RX CAROTID STENT.
ev3 Inc., Plymouth, Minn., (NASDAQ:EVVV) has announced U.S. Food
and Drug Administration approval of the PROTEGE(R) RX Carotid Stent.
This stent, when used in conjunction with the ev3 embolic . . .
MOLECULAR DEVICES UNVEILS ARCTURUS MICRODISSECTION.
Molecular Devices Corporation (NASDAQ:MDCC), Sunnyvale, Calif., a
leader in innovative solutions for drug discovery and life sciences
research, unveiled the Arcturus(XT) laser capture . . .
ROCHE/CALIPER LAUNCH INTERGRATED SOLUTION WITH LIFECYCLE
480.
Roche Diagnostics and Caliper Life Sciences, Inc. have announced a
joint product offering that combines Caliper's Twister(R) II
Microplate Handler and Roche's LightCycler(R) 480 Real-Time . . .
ESA CORONA CAD ENABLES METHODS DEVELOPMENT.
ESA Biosciences, a Magellan Biosciences company, Chelmsford, Mass.,
has announced that a top-ten pharmaceutical company has now standardized
on the Corona CAD (Charged Aerosol Detector) for a . . .
KYPHON SIGNS PACT TO ACQUIRE SPINE-RELATED ASSETS OF
DISC-O-TECH.
Kyphon Inc. (NASDAQ:KYPH), Sunnyvale, Calif., has signed two
definitive agreements (the "Transactions") to acquire all of
the spine-related product assets and associated intellectual . . .
CORDIS ENTERPRISE VASCULAR SYSTEM GETS CE MARK IN EUROPE.
Cordis Neurovascular, Inc., Waterloo, Belgium, has announced that
the CORDIS ENTERPRISE(TM) Vascular Reconstruction Device and Delivery
System received the CE Mark in Europe for use with occlusive . . .
CORNOVA GETS CE MARK FOR VALECOR CORONARY STENT SYSTEM.
CorNova, Inc., a developer of advanced endovascular devices and
catheters, and CardioTech International, Inc. (AMEX:CTE) have reported
that CorNova GmbH, a wholly-owned German subsidiary of . . .
THORATEC SUBMITS PMA FOR BIT APPROVAL FOR HEARTMATE II.
Thoratec Corporation (NASDAQ:THOR), Pleasanton, Calif., a world
leader in products to treat cardiovascular disease, said today that it
has completed the submission of its PMA (Pre-Market Approval) . . .
PROTOCOL FOR US DT THERAPY TRIAL OF VENTRASSIST APPROVED.
Ventracor has announced the United States Food & Drug
Administration (FDA) has granted conditional approval of the protocol
for the US Destination Therapy (DT) trial of the VentrAssist.
. . .
SMARTTOUCH/S&S MEDCART DEBUT SECURE MEDICAL DISPENSING
CART.
smartTOUCH Medical, Inc., a wholly owned subsidiary of bioMETRX,
Inc. (BULLETIN BOARD: BMRX) a leader in fingerscan technology and
products, and S & S MedCart, Inc, of Houston, Texas, a . . .
ELASTICITY IMAGING IDENTIFIES CANCERS/REDUCES BIOPSIES.
A new ultrasound technique allows radiologists to accurately
distinguish benign from malignant breast lesions. Using elasticity
imaging, researchers correctly identified both cancerous and . . .
AMICAS DEBUTS RADSTREAM TO IMPROVE RADIOLOGY
PRODUCTIVITY.
AMICAS, Inc. (NASDAQ:AMCS), Boston, Mass. a leader in radiology and
medical image and information management solutions, has debuted
RadStream(TM), a new product designed to revolutionize . . .
VICTHOM HUMAN BIONICS MEETS WITH FDA FOR NEUROSTEP
PRE-IDE.
Victhom Human Bionics Inc. (TSX: VHB), Quebec, met recently with
the Center for Devices and Radiological Health (CDRH), United States
(US) Food and Drug Administration (FDA) to discuss the . . .
AETHLON MEDICAL TO SUBMIT BIOSHIELD IDE.
Aethlon Medical, Inc., (OTCBB:AEMD), San Diego, has announced that
its first regulatory submission in the United States will focus on
bioterror threats addressed under Project BioShield. In this . . .
CYPHER STENT OUTPERFORMS TAXUS STENT IN LONG CORONARY
LESIONS.
Results from a multicenter, prospective, randomized clinical trial
indicate that the CYPHER(R) Stent performed better than the Taxus Stent
in procedures involving long coronary lesions, which are . . .
ABBOTT REPORTS POSITIVE SUBSET RESULTS FOR XIENCE V.
A subset analysis of diabetic patients in the SPIRIT II Clinical
trial of the XIENCE(TM) V Everolimus Eluting Stent System showed nearly
identical rates of in-stent late loss at six months in . . .
|
|